Provider review
Mint Med review
Locks your price for life at every dose, and sells one drug at two prices right now.
The all-doses promise is written into the checkout plan itself, so it is real. It also means a quarter dose is locked at the full-dose rate. Meanwhile the same tirzepatide is live at two different rates on two pages.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Mint Med
$149/mo semaglutide, all doses, price locked for life
FDA warning letter · Mint Med · June 2026 · addressed to Glow Medispa, LLC dba Mint Med. Details in our review.
- Vs median
- $20/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take a quarter dose here and you pay a full dose's price, and you pay it for as long as you stay — price locked for life, all doses included, cuts both ways. Credit the way it is stated: the promise is encoded in the subscription plan you actually check out with, not just in marketing copy, so it will not quietly change on you. Mint Med is also honest that it is not the pharmacy, and refunds in full if the provider declines to treat you. Then the numbers stop lining up. The same compounded tirzepatide is purchasable at two different monthly rates on two live product pages, with different prepay ladders behind each, so what you pay depends on which page you landed on. The bar running across every page advertises a third figure that matches no product at all. And no pharmacy is named.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are starting low and expect to climb, and want a rate that is pinned in writing while you do
- You want the all-doses promise visible at checkout rather than only on a landing page
- You want a full refund if the provider declines to treat you
Look elsewhere if
- You are taking less to spend less. A lifetime lock works against you at a low dose
- You are shopping tirzepatide and want one price. Two are live at once, on two pages
- You are budgeting from the bar across the top of the site. That figure matches no product
- You want the dispensing pharmacy named, or to know whether your state is served
What it actually costs
Price as published
$149.00/month compounded semaglutide, sold under the selling plan "$149/month – Lifetime Price (All Doses Included)" with delivery every one month · compounded tirzepatide is live twice at two different month-to-month rates, $179.00 and $185.00, depending which product page you land on · semaglutide prepay 3 Months $387 ($129/mo), 6 Months $714 ($119/mo), 12 Months $1,308 ($109/mo, described as "3 month supply every 90 days for a year") · tirzepatide ($185 product) 2 Months $350, 3 Months $495, 6 Months $900, 12 Months $1,680; the $179 product offers only $450 for 3 months · both products show a struck-through "Regular price $250.00" · the sitewide bar advertises "GLP-1 All Doses $159 per month", a figure matching no live product
- Vs median
- $20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. The all-doses promise is written into the selling plan a buyer subscribes to, not just the marketing page, so the figure genuinely will not move — in either direction. A low-dose patient locks in the full-dose rate for as long as they stay.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- "ALL DOSES INCLUDED" is stated in the price block and encoded in the selling-plan names themselves, so the promise survives into checkout rather than living only in marketing copy
- "PRICE LOCKED FOR LIFE" is an unusually specific commitment — a patient titrating from a starting dose to the top of the range is told in advance the bill will not move
- Honest that it is not the pharmacy: "MintMed does not manufacture, compound, or dispense medications"
- A full refund is promised if the provider declines treatment
- The prepay rungs publish both the total charged and the implied monthly figure
Pharmacy, labs and oversight
Mint Med does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Mint Med publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Mint Med in June 2026. It is addressed to Glow Medispa, LLC dba Mint Med — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Mint Med is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Mint Med sells compounded semaglutide and compounded tirzepatide through a storefront with subscription selling plans, offering month-to-month delivery alongside prepaid two-, three-, six- and twelve-month plans. The all-doses promise is encoded in the selling-plan names themselves rather than living only in marketing copy. It states plainly that it is not the pharmacy: "MintMed does not manufacture, compound, or dispense medications. Actual packaging, labeling, and pharmacy may vary." Two tirzepatide products are purchasable at once at different prices.
The honest cons
ALL DOSES INCLUDED, WITH THE PRICE LOCKED FOR LIFE, means a quarter dose is billed exactly as a full one — and stays that way for as long as you stay
- THE SAME TIRZEPATIDE IS SOLD AT TWO PRICES AT ONCE — $179.00/month on one product and $185.00/month on another, both live, with different prepay ladders behind them. Which you pay depends on which page you land on
- The sitewide announcement bar reads "GLP-1 All Doses $159 per month" on every page, including the semaglutide product page selling at $149.00. That figure corresponds to no live product or selling plan
- A single testimonial quoting a specific monthly figure — "I was paying over $500/month… now $149 and my doctor is amazing" — is reused on the tirzepatide pages, where that figure is not the price
- "Limited spots for same-day doctor reviews — secure yours today!" is a scarcity device with no stated limit
- No compounding pharmacy is named and no list of states served is published
- The 12-month semaglutide plan is described as "3 month supply every 90 days for a year", and no page confirms that this totals twelve months of medication
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Mint Med is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#124 of 373
Ordered with the companies that pay us first, and Mint Med is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.